4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000110
Director sold 99 shares at an average $1,085.53 ($107,467)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RYAN ARTHUR F · Director
Table I: Non-derivative
30 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-01 | Sale : show line 1 in the form 10b5-1 | −1 | $1,053.22 | $1,053 | 17,881 | D |
| 2024-08-01 | Sale : show line 2 in the form 10b5-1 | −1 | $1,058.90 | $1,059 | 17,880 | D |
| 2024-08-01 | Sale : show line 3 in the form 10b5-1 | −1 | $1,062.71 | $1,063 | 17,879 | D |
| 2024-08-01 | Sale : show line 4 in the form 10b5-1 | −6 | $1,065.39 | $6,392 | 17,873 | D |
| 2024-08-01 | Sale : show line 5 in the form 10b5-1 | −4 | $1,066.33 | $4,265 | 17,869 | D |
| 2024-08-01 | Sale : show line 6 in the form 10b5-1 | −1 | $1,067.53 | $1,068 | 17,868 | D |
| 2024-08-01 | Sale : show line 7 in the form 10b5-1 | −1 | $1,068.08 | $1,068 | 17,867 | D |
| 2024-08-01 | Sale : show line 8 in the form 10b5-1 | −4 | $1,070.46 | $4,282 | 17,863 | D |
| Open-market sales · 99 sh · avg $1,085.53 · $107,467 | ||||||
Loading xslF345X05/edgardoc.xml…